Invokana Lawsuit Discussed Alleged Side Effects Linking Diabetes Type-2 Drug To Kidney Failure

March 29, 2016 – – TheProductLawyers.com reports on concerning reports that type-2 diabetes drug Invokana has been linked to the development of severe kidney damage and kidney failure through adverse event reports to the U.S. Food and Drug Administration. The agency described having received 50 adverse event reports concerning renal impairment and kidney failure among patients taking the drug within its first year on the market alone.

Invokana is a new-generation diabetes drug which was approved by the FDA in March of 2013. It works by managing blood sugar (glucose) levels in type-2 diabetes patients. It does this by blocking the kidneys from reabsorbing extra sugar and instead using them to remove that sugar from the body through urination. The drug was the first to be released out of a group of similar new-generation drugs known as an SGLT2 class inhibitors. This is an abbreviation for sodium-glucose cotransporter-2.

Due to the fact that Invokana relies heavily upon the kidneys to do its job, it is now being alleged that it can potentially damage the organs or cause them stress. Many believe that these risks can be exacerbated among patients who have preexisting kidney damage, as is common for many diabetics due to the fact that diabetes is a condition which is notably hard on the kidneys.

The U.S. Food and Drug Administration announced a public safety communication on December 4, 2015, which discussed new label warning requirements for Invokana which would better address certain potential side effect risks. The agency noted that they had been in receipt of 19 reports detailing adverse events among patients who had claimed they developed life-threatening complications which started as urinary tract infections (UTIs) but later spread to blood or kidney infections. Because Invokana helps the kidneys to dispose of excess sugar through urine, the presence of extra sugar in this area can also cause the presence of extra bacteria. Each of the 19 patients detailed within these reports claim to have required hospitalization and dialysis, a kidney failure treatment. When kidney damage is sustained, it cannot be reversed, and therefore, patients with substantially damaged kidneys generally require dialysis until they are able to find a kidney transplant.

Kidney damage has also been the subject of a recent Invokana lawsuit, in addition to another potentially life-threatening side effect called diabetic ketoacidosis. Lawsuits discussing Invokana side effect allegations are filed against Invokana manufacturer and Johnson & Johnson subsidiary Janssen Pharmaceuticals.

The attorneys of Banville Law understand how concerning these potential side effect links are for patients currently using Invokana. They are dedicated to maintaining public awareness of any important safety information on Invokana or other similar SGLT2 class inhibitor drugs. To better accomplish this, they sponsor the online resource website TheProductLawyers.com. Additionally, the attorneys of Banville Law are now working to help patients who have taken these types of drugs and suffered from adverse events that they believe were caused by their use of the drugs. Banville Law attorneys want to ensure that these patients are given the important opportunity to investigate their legal rights in the matter. To help those wishing to investigate their legal options fully, the attorneys of Banville Law are offering complimentary legal consultations to affected individuals at this time, who may be eligible for significant compensation.

To ask questions regarding Invokana lawsuits, or to request additional information, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60008954